Autonomix Medical, Inc. Common StockAMIXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P33
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025112.36%
2024198.66%
202318209.17%
20220.00%